ScandiDos AB (FRA:2FV) Other Current Receivables: €0.20 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2FV ScandiDos AB FRA:2FV
47 GF Score
Price €0.05
GF Value €0.06
! 4 Warning Signs
View Full Analysis

What is ScandiDos AB Other Current Receivables?

ScandiDos AB FRA:2FV -5.21% 47 Other Current Receivables is €0.20 Mil as of Apr. 2026. GuruFocus rates FRA:2FV with a GF Score™ of 47/100 and a GF Value™ of €0.06. The stock has 4 warning signs investors should review.

ScandiDos AB's Other Current Receivables for the quarter that ended in Apr. 2026 was €0.20 Mil.

ScandiDos AB's quarterly Other Current Receivables increased from Oct. 2025 (€0.30 Mil) to Jan. 2026 (€0.37 Mil) but then stayed the same from Jan. 2026 (€0.37 Mil) to Apr. 2026 (€0.20 Mil).

ScandiDos AB's annual Other Current Receivables increased from Apr. 2024 (€0.27 Mil) to Apr. 2025 (€0.30 Mil) but then declined from Apr. 2025 (€0.30 Mil) to Apr. 2026 (€0.20 Mil).

ScandiDos AB Other Current Receivables Related Terms

ScandiDos AB Other Current Receivables Historical Data

* Premium members only.

The historical data trend for ScandiDos AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ScandiDos AB Other Current Receivables Chart

ScandiDos AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.29 0.27 0.30 0.20

ScandiDos AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.30 0.30 0.37 0.20
FRA:2FV
47GF Score
ScandiDos AB FRA:2FV
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ScandiDos AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €0.20 Mil mean?
ScandiDos AB (FRA:2FV) has a Other Current Receivables of €0.20 Mil as of Apr. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on ScandiDos AB and its competitors.
Is ScandiDos AB's Other Current Receivables too high?
ScandiDos AB's current Other Current Receivables is €0.20 Mil. Overall, ScandiDos AB has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does ScandiDos AB's Other Current Receivables compare to ABT and SYK?
ScandiDos AB's Other Current Receivables of €0.20 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on ScandiDos AB and its competitors. ScandiDos AB's current Other Current Receivables is €0.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ScandiDos AB stock overvalued right now?
ScandiDos AB (FRA:2FV) has a current Other Current Receivables of €0.20 Mil. The stock's GF Value™ is €0.06, compared to a current price of €0.05 — trading 24.2% below its estimated fair value. The current Other Current Receivables is €0.20 Mil. ScandiDos AB's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For ScandiDos AB (FRA:2FV), the current Other Current Receivables is €0.20 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ScandiDos AB (FRA:2FV) Overvalued in 2026?

Based on GuruFocus' analysis, ScandiDos AB stock appears to be undervalued. The current stock price of €0.05 is trading 24.2% below its estimated GF Value™ of €0.06.

Key valuation signals for FRA:2FV:

  • Other Current Receivables: €0.20 Mil
  • GF Value™: €0.06 vs. price of €0.05 (24.2% below fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the FRA:2FV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ScandiDos AB Business Description

Other Exchanges SDOS:Sweden
Address Uppsala Science Park, Uppsala, SWE, SE-751 83
ScandiDos AB is engaged in providing radiation therapy for cancer. Its product, Delta4 Phantom+, and its various hardware and software options are at the heart of everything ScandiDos does, from product development and production to marketing, sales, and customer support. With Delta4 HexaMotion ScandiDos has successfully developed a motion platform that recreates the movement of the tumor in six dimensions and independently simulates the patient's breathing movement.
47GF Score

Get the complete analysis for FRA:2FV

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.05
Price
€0.06
GF Value